Data / Research funding / Men's Health Research
Men's Health Research: 985 NIH awards ($1.9B) to 250 organizations
985 NIH awards ($1.9B) in the NIH spending category Men's Health Research, to 250 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 985 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| HIV Prevention Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $213,590,410 | June 1, 2006 | November 30, 2027 | COHEN, MYRON SCOTT | reporter.nih.gov |
| HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $74,729,762 | June 29, 2006 | November 30, 2027 | DONNELL, DEBORAH J | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,477,809 | February 1, 2007 | November 30, 2027 | ERON, JOSEPH J | reporter.nih.gov |
| Los Angeles CRS for the MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $22,107,486 | April 15, 2019 | September 30, 2026 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| University of Pittsburgh MACS/WIHS CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,988,029 | April 1, 2019 | September 30, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| UZ-UCSF CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,624,239 | September 9, 2025 | November 30, 2027 | CHIRENJE, ZVAVAHERA MIKE | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| The RADAR cohort study of multilevel Influences on HIV and substance use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,251,651 | April 15, 2014 | April 30, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| The Pacific Northwest Prostate Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $9,924,776 | September 19, 2002 | August 31, 2028 | NELSON, PETER S | reporter.nih.gov |
| Cancer Epidemiology Cohort in Male Health Professionals | NIH | National Cancer Institute | 2021 to 2025 | $7,706,351 | August 21, 2012 | July 31, 2027 | MUCCI, LORELEI | reporter.nih.gov |
| University of Arizona Cancer Prevention Clinical Trials Network | NIH | National Cancer Institute | 2021 to 2025 | $7,572,043 | August 16, 2019 | July 31, 2031 | THOMPSON, PATRICIA ANN | reporter.nih.gov |
| iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,046,172 | August 15, 2019 | July 31, 2031 | VILAR SANCHEZ, EDUARDO | reporter.nih.gov |
| Early Life Air Pollution Exposures as a Risk Factor for Neurodevelopmental Disorders | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $6,692,816 | August 1, 2021 | July 31, 2029 | CORY-SLECHTA, DEBORAH A | reporter.nih.gov |
| Aurum Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,678,965 | December 1, 2020 | November 30, 2027 | CHURCHYARD, GAVIN JOHN | reporter.nih.gov |
| Harnessing the power of text messaging to reduce HIV incidence in adolescent males across the United States | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $6,477,724 | September 23, 2021 | December 8, 2027 | YBARRA, MICHELE L. | reporter.nih.gov |
| La Spada Outstanding Investigator Award | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,002,158 | May 15, 2021 | April 30, 2029 | LA SPADA, ALBERT R | reporter.nih.gov |
| Optimizing HIV prevention for high-risk methamphetamine-using men who have sex with men | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,855,396 | April 8, 2022 | April 30, 2027 | GROV, CHRISTIAN | reporter.nih.gov |
| NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care | NIH | National Cancer Institute | 2021 to 2025 | $5,422,908 | March 5, 2019 | February 28, 2026 | BURSTEIN, HAROLD JOHN | reporter.nih.gov |
| Chicago Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,330,849 | February 1, 2007 | November 30, 2027 | ACHENBACH, CHAD J | reporter.nih.gov |
| Genomic and Genomic Variation in Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $5,164,514 | January 7, 2022 | April 30, 2027 | REBBECK, TIMOTHY RICHARD | reporter.nih.gov |
| Human Prostate Tumor Atlas Center | NIH | National Cancer Institute | 2024 to 2025 | $5,162,603 | September 1, 2024 | August 31, 2029 | DING, LI | reporter.nih.gov |
| Integrating targeted therapy and immunotherapy to break through cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,025,838 | September 1, 2016 | August 31, 2030 | ZHAO, JEAN | reporter.nih.gov |
| Modeling Precision Interventions for Prostate Cancer Control | NIH | National Cancer Institute | 2021 to 2025 | $4,423,369 | June 15, 2025 | August 31, 2026 | ETZIONI, RUTH D | reporter.nih.gov |
| Genetic Susceptibility and Biomarkers of Platinum-related Toxicities | NIH | National Cancer Institute | 2021 to 2025 | $4,370,186 | September 25, 2012 | June 30, 2027 | TRAVIS, LOIS B. | reporter.nih.gov |
| Regulation of proliferation and differentiation in the male germ line adult stem cell lineage | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,349,146 | June 1, 2020 | May 31, 2030 | FULLER, MARGARET T | reporter.nih.gov |
| Urology Centers Program Interactions Core (U24) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,277,500 | September 17, 2020 | July 31, 2030 | PENNISTON, KRISTINA L | reporter.nih.gov |
| Integrating the Visualization and Use of Stigma Data to Maximize the Impact of the Ending the HIV Epidemic Initiative | NIH | National Institute of Mental Health | 2022 to 2025 | $4,090,422 | July 8, 2022 | May 31, 2027 | BARAL, STEFAN DAVID | reporter.nih.gov |
| Pain Mechanisms in Fabry Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,085,512 | May 15, 2019 | March 31, 2026 | STUCKY, CHERYL LOUISE | reporter.nih.gov |
| Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,045,904 | March 24, 2020 | February 28, 2027 | RYBICKI-NEWMAN, MARIA | reporter.nih.gov |
| Bedside to bench resources for lower urinary tract research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $4,039,744 | September 15, 2022 | May 31, 2027 | STRAND, DOUGLAS WILLIAM | reporter.nih.gov |
| Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida | NIH | National Institute of Mental Health | 2022 to 2025 | $4,004,279 | August 4, 2022 | May 31, 2027 | NAAR, SYLVIE | reporter.nih.gov |
| Characterizing Sleep, ART Adherence and Viral Suppression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,926,963 | September 15, 2021 | July 31, 2027 | DUNCAN, DUSTIN T | reporter.nih.gov |
| Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,925,773 | July 1, 2021 | April 30, 2027 | DUNCAN, JOSEPH A | reporter.nih.gov |
| Characterizing the role of social, behavioral, and economic stigmas as determinants of HIV and mental health across the US | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,922,514 | September 22, 2021 | June 30, 2027 | BARAL, STEFAN DAVID | reporter.nih.gov |
| Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,898,240 | September 8, 2023 | January 5, 2029 | GAROFALO, ROBERT | reporter.nih.gov |
| Modeling and analytics for cancer diagnostics: traversing the data-evidence divide | NIH | National Cancer Institute | 2022 to 2025 | $3,872,365 | September 1, 2022 | August 31, 2029 | ETZIONI, RUTH D | reporter.nih.gov |
| Childhood Antecedents of Adult Cardiometabolic health: A Prospective Study of Low-Income Men | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,818,087 | August 1, 2021 | July 31, 2027 | MARSLAND, ANNA L | reporter.nih.gov |
| GEMS: Genomic approach to connecting Elevated germline Mutation rates with male infertility and Somatic health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,803,952 | September 1, 2021 | May 31, 2027 | HOTALING, JAMES | reporter.nih.gov |
| Heavy cannabis use, neurocognition and PrEP care engagement among young Black sexual minority men | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,790,453 | September 15, 2022 | June 30, 2027 | SCHNEIDER, JOHN | reporter.nih.gov |
| Efficacy of a PrEP uptake & Adherence Intervention among male sex workers using a 2-stage randomization design | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,717,256 | July 8, 2021 | March 31, 2027 | BIELLO, KATIE BROOKS | reporter.nih.gov |
| Genetic modifiers of Duchenne Muscular Dystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,704,232 | May 15, 2014 | July 31, 2027 | FLANIGAN, KEVIN M | reporter.nih.gov |
| Epigenetic gene regulation in the germline | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,700,633 | July 5, 2021 | December 31, 2026 | NAMEKAWA, SATOSHI | reporter.nih.gov |
| Enhancing immune regulation in gene therapy for hemophilia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,664,714 | July 1, 2016 | June 30, 2029 | HERZOG, ROLAND W. | reporter.nih.gov |
| Genetic Predictors of Prostate Cancer Survival | NIH | National Cancer Institute | 2021 to 2025 | $3,655,797 | January 15, 2021 | December 31, 2026 | KLEIN, ROBERT J. | reporter.nih.gov |
| PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy | NIH | National Cancer Institute | 2021 to 2025 | $3,606,632 | July 1, 2021 | June 30, 2027 | GRIMM, JAN | reporter.nih.gov |
| A prospective study of male factors, fertility, and pregnancy outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,601,732 | August 5, 2021 | April 30, 2027 | WISE, LAUREN A | reporter.nih.gov |
| Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,561,650 | September 1, 2023 | June 30, 2028 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| Violence and viral suppression among men living with HIV | NIH | National Institute of Mental Health | 2021 to 2025 | $3,556,062 | December 1, 2020 | December 30, 2026 | KAHLE, ERIN M | reporter.nih.gov |
| Viral Gene Therapy for Menkes Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,444,962 | September 1, 2023 | June 30, 2027 | KALER, STEPHEN GERARD | reporter.nih.gov |
| Chemical tools for developmental biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,426,216 | April 1, 2018 | June 30, 2028 | CHEN, JAMES K | reporter.nih.gov |
| Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,403,254 | February 9, 2021 | January 31, 2027 | GOLDKORN, AMIR | reporter.nih.gov |
| Evaluation of a Treponema pallidum transcription mediated amplification assay for Syphilis Screening | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,378,896 | June 8, 2021 | May 31, 2027 | GOLDEN, MATTHEW R | reporter.nih.gov |
| Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,369,470 | July 7, 2016 | December 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches | NIH | National Cancer Institute | 2021 to 2025 | $3,352,278 | March 2, 2021 | February 28, 2027 | FREEDMAN, MATTHEW L | reporter.nih.gov |
| Dystrophin Replacement | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,349,499 | April 1, 1991 | April 30, 2026 | CHAMBERLAIN, JEFFREY S | reporter.nih.gov |
| Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies | NIH | National Cancer Institute | 2022 to 2025 | $3,342,109 | September 1, 2022 | August 31, 2027 | FREEDMAN, MATTHEW L | reporter.nih.gov |
| Adverse Daily Experiences in Older Men Susceptible to or Living with HIV | NIH | National Institute on Aging | 2022 to 2025 | $3,337,207 | September 15, 2022 | May 31, 2027 | RAMIREZ-VALLES, JESUS | reporter.nih.gov |
| Comparative studies on the regulation of metabolism during sperm capacitation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,315,914 | August 21, 2017 | May 31, 2027 | BUCK, JOCHEN | reporter.nih.gov |
| Career Development in Pediatric and Medical Oncology | NIH | National Cancer Institute | 2021 to 2025 | $3,314,336 | September 30, 1997 | August 31, 2026 | MESHINCHI, SOHEIL | reporter.nih.gov |
| Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring | NIH | National Cancer Institute | 2021 to 2025 | $3,288,067 | December 1, 2020 | November 30, 2026 | VIGNERON, DANIEL B | reporter.nih.gov |
| A savings intervention to reduce men's engagement in HIV risk behaviors | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,287,361 | April 1, 2021 | March 30, 2027 | THIRUMURTHY, HARSHA | reporter.nih.gov |
| Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients | NIH | National Cancer Institute | 2021 to 2025 | $3,266,535 | July 1, 2021 | June 30, 2027 | VIGNERON, DANIEL B | reporter.nih.gov |
| Cabotegravir PrEP: Actionable Robust Evidence for Translation into Practice (CABARET) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,263,063 | September 21, 2022 | November 30, 2027 | MARCUS, JULIA L. | reporter.nih.gov |
| The push and pull of inflammation on HIV susceptibility: impact of host variation in CD101 and AXL | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,239,050 | July 12, 2022 | June 30, 2027 | LINGAPPA, JAIRAM RAO | reporter.nih.gov |
| Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT) | NIH | National Cancer Institute | 2022 to 2025 | $3,210,795 | September 15, 2022 | August 31, 2027 | NOWAK, REBECCA G. | reporter.nih.gov |
| Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,262 | September 20, 2013 | June 30, 2028 | PYLE, APRIL D | reporter.nih.gov |
| Testing a pre-visit mobile health app to promote adolescent healthcare | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,197,247 | September 21, 2022 | August 31, 2027 | MARCELL, ARIK V | reporter.nih.gov |
| 3D High Resolution Magnetic Resonance Fingerprinting for Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,177,909 | August 1, 2021 | July 31, 2027 | JIANG, YUN | reporter.nih.gov |
| Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,177,343 | July 8, 2021 | June 30, 2027 | YANG, HUSHAN | reporter.nih.gov |
| Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern | NIH | National Cancer Institute | 2021 to 2025 | $3,170,165 | March 29, 2005 | June 30, 2028 | SANDA, MARTIN G. | reporter.nih.gov |
| IND-enabling studies of non-immunogenic gene therapy for ultra-rare DMD patients excluded from dystrophin trials | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $3,161,261 | August 1, 2024 | July 31, 2027 | STEDMAN, HANSELL H | reporter.nih.gov |
| Intimate Partner Violence and HIV Prevention among Sexual Minority Men | NIH | National Institute of Mental Health | 2021 to 2025 | $3,158,226 | May 1, 2021 | February 28, 2027 | STORHOLM, ERIK D. | reporter.nih.gov |
| Enabling clinical tissue microstructure imaging as a diagnostic tool in wide-bore 3T MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $3,146,296 | September 1, 2023 | August 31, 2028 | FOO, THOMAS K | reporter.nih.gov |
| The role of semen in induction of paternal-specific tolerance during pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,142,758 | February 25, 2021 | January 31, 2027 | VOJTECH, LUCIA N | reporter.nih.gov |
| MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young Men | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $3,138,142 | September 21, 2023 | June 30, 2029 | SCHNALL, REBECCA | reporter.nih.gov |
| Transrectal Histotripsy for Focal Ablation of Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,132,373 | September 23, 2022 | August 31, 2027 | SCHADE, GEORGE R | reporter.nih.gov |
| The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratios | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,121,386 | July 18, 2024 | June 30, 2029 | LUETKEMEYER, ANNE FREY | reporter.nih.gov |
| Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,115,633 | March 19, 2021 | February 28, 2027 | TUCKER, JOSEPH DAVID | reporter.nih.gov |
| Cardiovascular Consequences of Duchenne and Becker Muscular Dystrophinopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,104,268 | September 1, 2021 | August 31, 2027 | WITMAN, MELISSA A.H. | reporter.nih.gov |
| Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,074,527 | May 1, 2021 | April 30, 2027 | MANHART, LISA E | reporter.nih.gov |
| A transdisciplinary approach for dissecting stem cell states in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,070,312 | September 20, 2021 | August 31, 2026 | RABADAN, RAUL | reporter.nih.gov |
| Multiethnic GWAS and TWAS to Inform Risk Prediction for Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,068,628 | May 1, 2025 | April 30, 2027 | HAIMAN, CHRISTOPHER ALAN | reporter.nih.gov |
| Identifying factors associated with prostate cancer progression and survival in African American men: The RESPOND Cohort | NIH | National Cancer Institute | 2024 to 2025 | $3,024,739 | July 23, 2024 | June 30, 2029 | HAIMAN, CHRISTOPHER ALAN | reporter.nih.gov |
| RCT of a parent-focused intervention to reduce HIV risk in adolescent MSM | NIH | National Institute of Mental Health | 2022 to 2025 | $3,017,981 | March 14, 2022 | February 28, 2027 | HUEBNER, DAVID M | reporter.nih.gov |
| Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,008,190 | September 5, 2022 | August 31, 2027 | MADABHUSHI, ANANT | reporter.nih.gov |
| Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI | NIH | National Cancer Institute | 2021 to 2025 | $2,990,455 | September 23, 2021 | August 31, 2027 | METZGER, GREGORY JOHN | reporter.nih.gov |
| Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease | NIH | National Cancer Institute | 2021 to 2025 | $2,965,890 | March 1, 2021 | August 31, 2026 | LAVIOLETTE, PETER S | reporter.nih.gov |
| Reproductive Hormones - Biological and Molecular Actions | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,952,543 | September 1, 1974 | March 31, 2030 | LONARD, DAVID M | reporter.nih.gov |
| Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,948,443 | August 6, 2021 | December 31, 2026 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Stigma and Substance Use as Barriers to PrEP Linkage, Uptake, Adherence, and Persistence among BMSM | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,945,558 | May 15, 2021 | March 31, 2027 | EATON, LISA A | reporter.nih.gov |
| Molecular mechanisms underlying lineage plasticity in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,937,823 | April 1, 2025 | March 31, 2027 | BELTRAN, HIMISHA | reporter.nih.gov |
| The ESPINA Study 19th Year Follow-Up: A Longitudinal Investigation of Pesticide Exposures in relation to Fertility and Hormonal Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,937,308 | September 23, 2025 | June 30, 2030 | SUAREZ, JOSE RICARDO | reporter.nih.gov |
| Early clinial trials for Angelica herbal supplements for prostate cancer interception | NIH | National Cancer Institute | 2022 to 2025 | $2,932,860 | September 1, 2022 | August 31, 2027 | LU, JUNXUAN | reporter.nih.gov |
| Preventing invasive prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,928,553 | September 19, 2023 | August 31, 2028 | BERGAN, RAYMOND C. | reporter.nih.gov |
| Understanding and targeting epigentic regulation of immune evasion in prostate cancer | NIH | National Cancer Institute | 2025 | $2,895,540 | August 1, 2025 | July 31, 2029 | CAI, LING | reporter.nih.gov |
| Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,871,021 | August 11, 2022 | May 30, 2025 | WINUTHAYANON, WIPAWEE | reporter.nih.gov |
| CHEMICAL SYNTHESIS FACILITY FOR CONTRACEPTIVE DEVELOPMENT | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,852,434 | September 29, 2022 | September 28, 2026 | GURVICH, VADIM | reporter.nih.gov |
| A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,849,004 | September 21, 2022 | August 31, 2029 | JOHNSEN, JILL MARIE | reporter.nih.gov |
| Effectiveness and implementation of text messaging to improve HIV testing in sexual and gender minority adolescents | NIH | National Institute of Mental Health | 2022 to 2025 | $2,840,340 | April 5, 2022 | January 31, 2027 | MACAPAGAL, KATHRYN ROSE | reporter.nih.gov |
| Targeting apoptotic cells to enhance radiotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,817,814 | September 22, 2022 | August 31, 2027 | RAO, JIANGHONG | reporter.nih.gov |
| The eXtraordinarY Babies Study: Natural History of Health and Neurodevelopment in Infants with Sex Chromosome Trisomy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,817,119 | September 6, 2017 | March 31, 2028 | TARTAGLIA, NICOLE RENEE | reporter.nih.gov |
| Metabolomic Signatures of Urologic Chronic Pelvic Pain Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,812,460 | July 15, 2021 | April 30, 2027 | HENDERSON, JEFFREY P | reporter.nih.gov |
| Cytoskeletal Interactions of Dystrophin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,806,646 | July 15, 1994 | July 31, 2026 | ERVASTI, JAMES M | reporter.nih.gov |
| Hepatic gene transfer for the treatment of hemophilia B and other genetic diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,797,035 | September 1, 2000 | December 31, 2027 | KAY, MARK A | reporter.nih.gov |
| Alcohol and "Heat of the Moment" Sexual Decision Making among MSM: Identifying Mechanisms of Sexual Risk and Promoting Behavior Change Through Brief Intervention | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,792,224 | August 15, 2022 | May 31, 2027 | PALFAI, TIBOR P. | reporter.nih.gov |
| Epigenetic Regulation of Sex Differences in the Brain | NIH | National Institute of Mental Health | 2021 to 2025 | $2,764,708 | March 1, 2018 | January 31, 2028 | TOLLKUHN, JESSICA | reporter.nih.gov |
| Uncovering causal protein markers to improve prostate cancer etiology understanding and risk prediction in Africans and Europeans | NIH | National Cancer Institute | 2022 to 2025 | $2,762,045 | July 1, 2022 | June 30, 2027 | WU, LANG | reporter.nih.gov |
| High throughput infrastructure for reaction screening and bioassays | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $2,752,647 | June 29, 2022 | May 31, 2027 | COOKS, ROBERT GRAHAM | reporter.nih.gov |
| Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,739,005 | May 10, 2021 | April 30, 2027 | CAMPBELL, JOSHUA D | reporter.nih.gov |
| Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,735,326 | August 1, 2022 | May 31, 2027 | LOZUPONE, CATHERINE | reporter.nih.gov |
| Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,733,165 | May 1, 2022 | April 30, 2027 | PILLARSETTY, NAGAVARAKISHORE | reporter.nih.gov |
| Systemic RNA Delivery to Tumors | NIH | National Cancer Institute | 2021 to 2025 | $2,731,905 | December 21, 2015 | June 30, 2027 | SHI, JINJUN | reporter.nih.gov |
| Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,725,938 | February 4, 2021 | December 31, 2026 | MAVES, LISA | reporter.nih.gov |
| Hemophilia Point-of-Care Monitoring Device and App | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,724,565 | September 10, 2020 | February 28, 2027 | CHAN, EUGENE YAN-HO | reporter.nih.gov |
| Metastasis of PTEN Mutant Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,701,454 | September 1, 2022 | August 31, 2027 | TROTMAN, LLOYD C | reporter.nih.gov |
| LRRC8 anion channels, superoxide and RhoA in diabetic erectile dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,699,596 | May 1, 2022 | April 30, 2027 | WEBB, R CLINTON | reporter.nih.gov |
| Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,698,545 | April 1, 2022 | March 31, 2027 | DAILY, JOHANNA PATRICIA | reporter.nih.gov |
| Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction | NIH | National Cancer Institute | 2021 to 2025 | $2,692,281 | July 6, 2021 | June 30, 2026 | MORAN, AMY E | reporter.nih.gov |
| Plk1 as a prognostic biomarker for prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,686,273 | July 1, 2021 | June 30, 2026 | LIU, XIAOQI | reporter.nih.gov |
| Defining the therapeutic efficacy, tolerogenic potential, and genotoxicity of liver-targeted AAV gene therapy for hemophilia A | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,682,494 | September 15, 2022 | June 30, 2027 | ALMEIDA-PORADA, GRACA DUARTE | reporter.nih.gov |
| EFFICACY TRIAL OF A PROGRAM FOR WEIGHT LOSS FOR HISPANIC FATHERS AND INCREASED PHYSICAL ACTIVITY FOR THEIR CHILDREN: HEALTHY DADS, HEALTHY KIDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,681,651 | September 15, 2021 | August 31, 2026 | O'CONNOR, TERESIA MARGARETA | reporter.nih.gov |
| Mechanisms of neuromuscular degeneration in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,675,706 | September 1, 2021 | May 31, 2027 | LIEBERMAN, ANDREW P | reporter.nih.gov |
| Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies | NIH | National Cancer Institute | 2022 to 2025 | $2,663,847 | August 12, 2022 | July 31, 2027 | ROSSER, B R SIMON | reporter.nih.gov |
| Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,654,692 | July 1, 2020 | June 30, 2026 | SCHWARTZ, LAWRENCE H | reporter.nih.gov |
| Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,642,372 | September 1, 2022 | August 31, 2027 | YAMOAH, KOSJ | reporter.nih.gov |
| Leveraging data synthesis to identify optimal and robust strategies for HIV elimination among substance-using MSM | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,637,647 | May 1, 2022 | February 28, 2027 | JANULIS, PATRICK FRANCIS | reporter.nih.gov |
| Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,630,502 | September 20, 2022 | August 31, 2027 | PATNAIK, AKASH | reporter.nih.gov |
| Personalized prevention for couples | NIH | National Institute of Mental Health | 2021 to 2025 | $2,616,164 | July 1, 2021 | June 30, 2027 | MITCHELL, JASON W | reporter.nih.gov |
| Paternal DDT exposure and programming of metabolic dysfunction and cancer in offspring: Understanding the role of sperm mirnas and placenta development | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,612,073 | February 20, 2021 | November 30, 2026 | DE ASSIS, SONIA | reporter.nih.gov |
| Sex differences in the contribution of cerebrovascular injury and immune activation to neurocognitive impairment in HIV infection | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,594,711 | May 15, 2022 | February 28, 2027 | CHOW, FELICIA C. | reporter.nih.gov |
| Enhancing the Efficacy of Docetaxel in Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,590,555 | July 13, 2022 | June 30, 2027 | BALK, STEVEN P. | reporter.nih.gov |
| Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry | NIH | National Cancer Institute | 2022 to 2025 | $2,585,593 | August 1, 2022 | July 31, 2027 | DOHERTY, JENNIFER ANNE | reporter.nih.gov |
| Pathways to improved adolescent mental health via an economic and gender equality intervention with conflict affected families | NIH | National Institute of Mental Health | 2022 to 2025 | $2,564,006 | February 15, 2021 | December 31, 2025 | GLASS, NANCY E | reporter.nih.gov |
| Paracrine actions of fibroblasts promote pathologic cardiac myocyte remodeling in Duchenne muscular dystrophy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,557,217 | July 1, 2021 | June 30, 2027 | WELC, STEVEN S | reporter.nih.gov |
| Preserving Genome Integrity In AAV-Mediated Gene Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,554,264 | February 1, 2022 | January 31, 2027 | SABATINO, DENISE E | reporter.nih.gov |
| Advancing Recovery Pathways and Support Services for Alcohol Use Disorders among Black Men and Women | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,553,722 | March 15, 2022 | December 31, 2026 | REIF, SHARON | reporter.nih.gov |
| Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,551,647 | January 1, 2022 | December 31, 2026 | MAHER, CHRISTOPHER A | reporter.nih.gov |
| Development of a universal gene therapy for hemophilia A or B with or without inhibitors | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,542,236 | April 10, 2024 | March 31, 2027 | MARGARITIS, PARIS | reporter.nih.gov |
| Pathogenic Alterations of the 3D Epigenetic Landscape in Dystrophin-Deficient Skeletal Muscles and Reversal by Dystrophin Re-Expression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,541,743 | August 1, 2009 | May 31, 2027 | PURI, PIER LORENZO | reporter.nih.gov |
| Effects of paternal aging on male reproductive biology and on future generations | NIH | National Institute on Aging | 2021 to 2025 | $2,534,407 | August 15, 2021 | April 30, 2027 | RANDO, OLIVER J | reporter.nih.gov |
| Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC | NIH | National Cancer Institute | 2022 to 2025 | $2,528,918 | September 16, 2020 | December 31, 2026 | HALABI, SUSAN | reporter.nih.gov |
| Mechanisms of prenatal opioid exposure on brain and behavior | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,525,552 | July 1, 2022 | April 30, 2027 | WU, PING | reporter.nih.gov |
| High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients | NIH | National Cancer Institute | 2022 to 2025 | $2,508,029 | December 17, 2021 | November 30, 2026 | PEPPONE, LUKE JOSEPH | reporter.nih.gov |
| STI Response and Recommendations Under PrEP (STIRRUP) | NIH | National Institute of Mental Health | 2022 to 2025 | $2,494,915 | February 1, 2022 | December 31, 2026 | JENNESS, SAMUEL | reporter.nih.gov |
| Genomics of spermatogenic impairment | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,487,694 | September 10, 2014 | June 30, 2027 | CONRAD, DONALD F. | reporter.nih.gov |
| ZC3H4 Driven Prostate Tissue Remodeling Triggered by Maladaptive Metabolic and Signaling Pathways | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,482,346 | September 15, 2025 | August 31, 2029 | PASCAL, LAURA ELLEN | reporter.nih.gov |
| Reaching the last 20%: a targeted HIV self-test secondary distribution intervention to engage high-risk men in Kenya | NIH | National Institute of Mental Health | 2022 to 2025 | $2,470,482 | June 6, 2022 | April 30, 2027 | MONTGOMERY, ELIZABETH TRASK | reporter.nih.gov |
| Preclinical analyses of advanced prostate cancer in genetically-engineered mice | NIH | National Cancer Institute | 2021 to 2025 | $2,462,511 | August 6, 2013 | January 31, 2028 | ABATE-SHEN, CORY | reporter.nih.gov |
| Multichannel Fluorescence Guided Surgery Tools Enabling Simultaneous Cancer Margin and Nerve Visualization in Prostatectomy | NIH | National Cancer Institute | 2022 to 2025 | $2,453,547 | May 10, 2022 | April 30, 2027 | GIBBS, SUMMER LYNNE | reporter.nih.gov |
| Sex-Specific Risk of Metabolic and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,450,619 | June 15, 2019 | June 30, 2025 | STAFFORD, JOHN MICHAEL | reporter.nih.gov |
| Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,441,514 | February 1, 2022 | January 31, 2028 | BISHAI, WILLIAM RAMSES | reporter.nih.gov |
| WHO-recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,440,496 | January 19, 2024 | November 30, 2028 | GRAHAM, SUSAN MARIE | reporter.nih.gov |
| Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens | NIH | National Cancer Institute | 2022 to 2025 | $2,436,399 | September 1, 2022 | July 31, 2027 | MCDONNELL, DONALD P | reporter.nih.gov |
| Ionization Detail - Biologically based treatment planning for particle therapy beyond LET-RBE | NIH | National Cancer Institute | 2022 to 2025 | $2,434,477 | September 1, 2022 | August 31, 2027 | FADDEGON, BRUCE | reporter.nih.gov |
| Enhancing the efficacy of androgen signaling inhibitors in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,422,948 | July 1, 2021 | June 30, 2026 | LIU, XIAOQI | reporter.nih.gov |
| Projection-specific gene expression in resilience to chronic stress | NIH | National Institute of Mental Health | 2022 to 2025 | $2,420,754 | September 8, 2016 | June 30, 2027 | ROBISON, ALFRED J | reporter.nih.gov |
| Men's Sexual Risk Behaviors: Alcohol, Sexual Aggression, and Emotional Factors | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,420,010 | June 5, 2018 | August 31, 2028 | DAVIS, KELLY CUE | reporter.nih.gov |
| Molecular Prosthetics and Lego Chemistry | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,415,883 | June 1, 2016 | February 29, 2028 | BURKE, MARTIN D | reporter.nih.gov |
| High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,415,000 | September 30, 2021 | July 31, 2027 | WESSELY, OLIVER | reporter.nih.gov |
| Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen Levels | NIH | National Cancer Institute | 2021 to 2025 | $2,414,500 | April 1, 2020 | March 31, 2030 | WITTE, JOHN S. | reporter.nih.gov |
| Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) | NIH | National Cancer Institute | 2022 to 2025 | $2,411,833 | February 4, 2022 | July 31, 2028 | HU, JIM | reporter.nih.gov |
| PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life? | NIH | National Cancer Institute | 2022 to 2025 | $2,408,587 | March 1, 2022 | February 28, 2027 | BAHLER, CLINTON DAVID | reporter.nih.gov |
| SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,406,599 | May 1, 2022 | January 31, 2026 | ANDERSON, DANIEL G | reporter.nih.gov |
| Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,406,187 | April 1, 2022 | March 31, 2027 | TONER, MEHMET | reporter.nih.gov |
| Targeting Castration Resistant Prostate Cancer via Potent Inhibition of Signaling Lipids | NIH | National Cancer Institute | 2022 to 2025 | $2,404,562 | September 1, 2022 | August 31, 2027 | KAOCHAR, SALMA | reporter.nih.gov |
| Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate Cancer | NIH | National Cancer Institute | 2024 to 2025 | $2,399,998 | September 2, 2024 | August 31, 2026 | LANGTON-WEBSTER, BEATRICE | reporter.nih.gov |
| Metabolomic profile of chronic distress in relation to diseases of aging across diverse populations | NIH | National Institute on Aging | 2023 to 2025 | $2,398,945 | September 15, 2017 | November 30, 2027 | HANKINSON, SUSAN E | reporter.nih.gov |
| Molecular Mechanisms Underlying the sex-Depended Maturation of Modulatory Systems. | NIH | National Institute of Mental Health | 2022 to 2025 | $2,392,059 | September 1, 2022 | July 31, 2027 | FUTAI, KENSUKE | reporter.nih.gov |
| How sex, host microenvironment, and immune responses shape acquisition of genital bacteria that increase HIV risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,387,782 | December 1, 2021 | November 30, 2026 | LIU, CINDY | reporter.nih.gov |
| Noninvasive assessment of detrusor pressure and dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,382,351 | February 15, 2022 | December 31, 2026 | FATEMI, MOSTAFA | reporter.nih.gov |
| Ultra-Low Count Quantitative SPECT for Alpha-Particle Therapies | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,381,642 | September 30, 2022 | June 30, 2027 | JHA, ABHINAV K | reporter.nih.gov |
| Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,380,224 | April 1, 2023 | March 31, 2028 | CHAKRABORTY, GOUTAM | reporter.nih.gov |
| Molecular imaging of novel PARP inhibitor nanomedicine delivery | NIH | National Cancer Institute | 2022 to 2025 | $2,377,967 | August 12, 2022 | July 31, 2027 | VANBROCKLIN, HENRY F. | reporter.nih.gov |
| MELT: Modulation of PSMA Expression for Lutetium Therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,363,818 | July 1, 2019 | June 30, 2026 | HOPE, THOMAS A | reporter.nih.gov |
| NOT-CA-24-111 Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) | NIH | National Cancer Institute | 2024 to 2025 | $2,357,813 | February 14, 2024 | December 31, 2027 | COOK, LINDA S | reporter.nih.gov |
| Effects of Acupuncture on Symptoms of Stable Angina: A Randomized Controlled Trial | NIH | National Institute of Nursing Research | 2023 to 2025 | $2,349,312 | September 19, 2023 | June 30, 2027 | DEVON, HOLLI A | reporter.nih.gov |
| Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,349,240 | April 7, 2021 | March 31, 2027 | MIRANTI, CYNTHIA K | reporter.nih.gov |
| A Family-Based HIV Prevention Program for Black Men to Protect Black Girls | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,348,430 | September 25, 2023 | May 31, 2028 | CROOKS, NATASHA KAELLA | reporter.nih.gov |
| Omics, mice and men: Development of precision transfusion medicine | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,341,220 | September 18, 2009 | July 31, 2028 | GLADWIN, MARK T | reporter.nih.gov |
| Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,339,824 | April 1, 2022 | March 31, 2027 | GAO, ALLEN C. | reporter.nih.gov |
| The natural history of C. trachomatis urethral infections in men who have sex with women | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,335,516 | July 5, 2023 | June 30, 2028 | NELSON, DAVID EMMET | reporter.nih.gov |
| A couples-based HIV biobehavioral prevention intervention | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,335,498 | July 15, 2023 | December 31, 2027 | MARTINEZ, OMAR | reporter.nih.gov |
| Essential roles for RNAi/hpRNAs to resolve intragenomic conflicts in the male germline | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,333,198 | May 3, 2022 | April 30, 2027 | LAI, ERIC C | reporter.nih.gov |
| Real time fine needle assessment of architectural heterogeneity in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,327,219 | January 18, 2019 | December 31, 2025 | XU, GUAN | reporter.nih.gov |
| Molecular mechanisms of prostate cancer metastasis | NIH | National Cancer Institute | 2021 to 2025 | $2,326,612 | January 1, 2015 | June 30, 2027 | ABATE-SHEN, CORY | reporter.nih.gov |
| Defining Sex-Specific Systemic and Gut Inflammatory Profiles in People Living with HIV | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,321,996 | January 3, 2023 | December 31, 2027 | SMITH, STACEY ABIGAIL | reporter.nih.gov |
| Moon and Sun Brothers: A group-based Prevention Intervention | NIH | National Institute of Mental Health | 2025 | $2,320,682 | September 20, 2023 | July 31, 2028 | SANCHEZ-VAZNAUGH, EMMA V. | reporter.nih.gov |
| Sexual Dimorphism in Bladder Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,318,010 | August 2, 2022 | July 31, 2027 | LI, XUE SEAN | reporter.nih.gov |
| Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | NIH | National Cancer Institute | 2021 to 2025 | $2,315,488 | April 1, 2015 | August 31, 2025 | SAWYERS, CHARLES L. | reporter.nih.gov |
| Interplay between tumor and microenvironment in bone metastasis | NIH | National Cancer Institute | 2021 to 2025 | $2,312,393 | April 1, 2021 | March 31, 2026 | FISHER, PAUL B | reporter.nih.gov |
| Increasing nerve-sparing radical prostatectomy rates using intraoperative nonlinear microscopy | NIH | National Cancer Institute | 2021 to 2025 | $2,308,361 | February 5, 2021 | January 31, 2027 | FUJIMOTO, JAMES G | reporter.nih.gov |
| Using Prostate Health Index and MRI in Combination for Cost-effectively Detecting High-Grade Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,307,356 | September 14, 2020 | June 30, 2026 | MURPHY, ADAM B | reporter.nih.gov |
| A cross-species preclinical platform to enhance the translation of new medicines | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $2,306,784 | December 1, 2023 | November 30, 2026 | GEISSE, NICHOLAS ANDREW | reporter.nih.gov |
| Super Resolution for Improved Multislice Prostate MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,303,815 | July 10, 2022 | May 31, 2026 | RIEDERER, STEPHEN J | reporter.nih.gov |
| Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI | NIH | National Cancer Institute | 2022 to 2025 | $2,302,630 | January 12, 2022 | December 31, 2026 | RUSU, MIRABELA | reporter.nih.gov |
| Stigma and the non-communicable disease syndemic in aging HIV positive and HIV negative MSM | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,300,401 | February 1, 2023 | August 31, 2027 | FRIEDMAN, MACKEY R | reporter.nih.gov |
| Mechanism of immune response to muscle-directed AAV gene transfer | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,292,756 | May 19, 2023 | April 30, 2028 | HERZOG, ROLAND W. | reporter.nih.gov |
| Cerebellar pathology in the absence of plasticity gating | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,290,342 | July 1, 2021 | April 30, 2026 | PUGH, JASON RICHARD | reporter.nih.gov |
| HFH-MSU CSRN ACCrual Enrollment and Screening Site | NIH | National Cancer Institute | 2024 to 2025 | $2,289,116 | March 7, 2025 | December 31, 2027 | NESLUND-DUDAS, CHRISTINE MARIE | reporter.nih.gov |
| DeepSRH: Transforming Molecular Cancer Screening with Stimulated Raman Histology and Deep Neural Networks | NIH | National Cancer Institute | 2025 | $2,284,054 | September 1, 2025 | August 31, 2029 | HOLLON, TODD CHARLES | reporter.nih.gov |
| Unraveling the intersection of substance use, inflammation, and HIV via hair levels | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,283,571 | July 1, 2023 | May 31, 2028 | GANDHI, MONICA | reporter.nih.gov |
| Theoretically Informed Behavioral Intervention to Enhance QOL and Prevent HIV-related Comorbidities | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $2,275,349 | September 15, 2024 | March 31, 2029 | RAMOS, SILVIA RAQUEL | reporter.nih.gov |
| Bridges-Round 2: Evaluating the Long-term Impact of a Family Economic Empowerment Intervention on HIV Risk Prevention and Care Continuum Outcomes among Orphaned Youth Transitioning to Young Adulthood | NIH | National Institute of Mental Health | 2022 to 2025 | $2,274,945 | March 17, 2022 | February 28, 2027 | SSEWAMALA, FRED M | reporter.nih.gov |
| Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes | NIH | National Cancer Institute | 2023 to 2025 | $2,274,110 | July 1, 2023 | June 30, 2028 | FREEDLAND, STEPHEN JAY | reporter.nih.gov |
| Intervention to Enhance Prep Persistence Among Men | NIH | National Institute of Mental Health | 2023 to 2025 | $2,257,996 | September 1, 2023 | November 30, 2028 | NUNN, AMY STEWART | reporter.nih.gov |
| Aligning financial incentives to promote rational use of active surveillance for prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,252,166 | April 1, 2022 | March 31, 2027 | SHAHINIAN, VAHAKN B | reporter.nih.gov |
| Digital Multiplexed Analysis of Circulating Nucleic Acids in Small-Volume Blood Specimens | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,239,028 | August 15, 2022 | May 31, 2026 | SMITH, ANDREW MICHAEL | reporter.nih.gov |
| Molecular Chaperones and Small Molecules | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,229,230 | February 1, 2008 | July 31, 2028 | GESTWICKI, JASON E | reporter.nih.gov |
| Evaluating the effectiveness of a mobile HIV prevention app to increase HIV and STI testing and PrEP initiation | NIH | National Institute of Mental Health | 2023 to 2025 | $2,221,938 | August 1, 2023 | April 30, 2028 | JONES, JEB | reporter.nih.gov |
| Genetic Studies of Large Palindromes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,207,672 | August 1, 2025 | July 31, 2029 | MUELLER, JACOB L | reporter.nih.gov |
| Improving HIV testing, linkage, and retention in care for men through U=U messaging | NIH | National Institute of Mental Health | 2022 to 2025 | $2,205,152 | June 1, 2022 | April 30, 2027 | MEDINA-MARINO, ANDREW | reporter.nih.gov |
| Addressing factors related to disparities in vasectomy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,201,542 | September 20, 2023 | August 31, 2028 | BORRERO, SONYA B. | reporter.nih.gov |
| Validation and Identification of Genetic Variants in Peyronie's and Dupuytren's Disease that Predispose to Fibrosis and Inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,194,947 | February 1, 2022 | December 31, 2026 | PASTUSZAK, ALEXANDER WOJCIECH | reporter.nih.gov |
| Development of Novel Targeted Therapeutic Agents for Castration Resistant Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,194,673 | June 3, 2022 | May 31, 2027 | OYELERE, ADEGBOYEGA | reporter.nih.gov |
| A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men | NIH | National Institute of Mental Health | 2025 | $2,187,174 | September 1, 2023 | June 30, 2028 | WHITFIELD, DARREN LOVELL | reporter.nih.gov |
| Hsp60 Regulation of Prostate Cancer Progression | NIH | National Cancer Institute | 2021 to 2025 | $2,185,351 | September 1, 2021 | August 31, 2027 | CHANDRA, DHYAN | reporter.nih.gov |
| Search for new genes involved in male infertility through novel approaches | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,184,123 | February 22, 2022 | November 30, 2026 | GARCIA, THOMAS | reporter.nih.gov |
| Lipoteichoic acid mediated modulation of chronic pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,182,686 | August 1, 2016 | June 30, 2027 | THUMBIKAT, PRAVEEN | reporter.nih.gov |
| Structure, function, and application of novel antagonists of the intrinsically disordered androgen receptor amino-terminal domain as imaging agents and therapeutics | NIH | National Cancer Institute | 2021 to 2025 | $2,182,643 | July 13, 2021 | June 30, 2027 | SADAR, MARIANNE D | reporter.nih.gov |
| Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,175,178 | February 1, 2021 | January 31, 2027 | DAMODARAN, CHENDIL | reporter.nih.gov |
| Platelet-derived FVIII Gene Therapy of Hemophilia A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,174,848 | July 1, 2010 | June 30, 2028 | SHI, QIZHEN | reporter.nih.gov |
| Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,170,868 | January 1, 2022 | December 31, 2026 | IPPOLITO, JOSEPH EDWARD | reporter.nih.gov |
| FINISHING HIV: An EHE model for Latinos Integrating One-Stop-Shop PrEP Services, a Social Network Support Program and a National Pharmacy Chain | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,164,050 | June 23, 2022 | May 31, 2028 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Oral HPV Research Among Latin Americans Living with HIV (ORAL - H² Study) | NIH | National Cancer Institute | 2022 to 2025 | $2,160,881 | September 12, 2022 | August 31, 2028 | GIULIANO, ANNA R. | reporter.nih.gov |
| Mechanisms of Prostate Cancer Metastasis | NIH | National Cancer Institute | 2021 to 2025 | $2,155,774 | September 17, 2021 | August 31, 2026 | FREEMAN, MICHAEL R. | reporter.nih.gov |
| Regulation of cellular plasticity and regeneration in Drosophila spermatogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,153,352 | June 1, 2020 | March 31, 2030 | MATUNIS, ERIKA L | reporter.nih.gov |
| A non-canonical role for EZH2 in rRNA methtlation | NIH | National Cancer Institute | 2021 to 2025 | $2,146,235 | July 15, 2021 | June 30, 2026 | CAO, QI | reporter.nih.gov |
| Eating Disorders Across Genders, Generations, and Adult Developmental Stages | NIH | National Institute of Mental Health | 2021 to 2025 | $2,141,933 | July 1, 2021 | April 30, 2027 | KEEL, PAMELA K. | reporter.nih.gov |
| Examining Therapeutic Change Mechanisms in an Affect Regulation, Father-Focused Intervention for Reducing Family Violence and Associated Symptoms in Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,135,789 | September 1, 2023 | May 31, 2028 | STOVER, CARLA S | reporter.nih.gov |
| Leveraging deep learning for markerless motion management in radiation therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,135,070 | April 1, 2021 | March 31, 2026 | XING, LEI | reporter.nih.gov |
| Couples Motivational Interviewing to reduce drug use and HIV risk in vulnerable male couples | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,117,921 | September 30, 2023 | July 31, 2028 | STARKS, TYREL J | reporter.nih.gov |
| Efficacy of mHealth + e-Navigator stepped care intervention for ART adherence among Latino men with HIV | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,105,451 | July 13, 2022 | March 31, 2027 | HOSPITAL, MICHELLE MARIE | reporter.nih.gov |
| HPV16 E6 Antibody Detection as an Early Marker for Oropharyngeal Cancer Among Men Living with HIV | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,105,308 | February 5, 2021 | April 30, 2026 | KUHS, KRYSTLE A. | reporter.nih.gov |
| A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression | NIH | National Cancer Institute | 2021 to 2025 | $2,103,278 | January 1, 2021 | December 31, 2025 | BRENNEN, WILLIAM NATHANIEL | reporter.nih.gov |
| Activity and therapeutic antagonism of the TP receptor in cardiomyopathy of muscular dystrophy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,092,461 | July 1, 2023 | June 30, 2027 | WEST, JAMES D | reporter.nih.gov |
| An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit | NIH | National Cancer Institute | 2022 to 2025 | $2,081,138 | September 5, 2022 | August 31, 2027 | MADABHUSHI, ANANT | reporter.nih.gov |
| Preserving Erectile Function by Quantifying the Nerve-Sparing step of the Robotic Prostatectomy | NIH | National Cancer Institute | 2023 to 2025 | $2,077,876 | July 7, 2022 | June 30, 2027 | HUNG, ANDREW | reporter.nih.gov |
| Sleep, Falls and Fractures in men and women: Role of nocturnal hypoxia | NIH | National Institute on Aging | 2021 to 2025 | $2,076,018 | September 15, 2021 | May 31, 2027 | CAULEY, JANE ANN | reporter.nih.gov |
| CKDu in Salvadoran and Nicaraguan Agricultural Communities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,075,171 | August 25, 2021 | June 30, 2028 | SCAMMELL, MADELEINE | reporter.nih.gov |
| Male pesticide exposure, reproductive health and epigenetics | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,072,965 | August 1, 2023 | June 30, 2028 | MINGUEZ ALARCON, LIDIA | reporter.nih.gov |
| CatSper regulation of sperm physiology and fertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,070,529 | August 1, 2019 | February 28, 2029 | CHUNG, JEAN-JU LUCIA | reporter.nih.gov |
| Nitric Oxide-Soluble Guanylate Cyclase Pathway as a Target for Male Bladder Outlet Obstruction and Lower Urinary Tract Symptoms in Aging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,068,975 | August 19, 2023 | June 30, 2027 | KANAI, ANTHONY JOHN | reporter.nih.gov |
| Leveraging whole-exome sequence data from diverse biobanks and cohorts to study rare coding variation in prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,067,626 | September 20, 2023 | August 31, 2028 | HAIMAN, CHRISTOPHER ALAN | reporter.nih.gov |
| Leveraging modulation of polyamine metabolism for therapeutic advantage in genetic disorders | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,060,044 | February 1, 2023 | January 31, 2028 | BACHMANN, ANDRE S | reporter.nih.gov |
| Optimizing Treatment of Prostate Cancer in Men living with HIV | NIH | National Cancer Institute | 2023 to 2025 | $2,059,152 | August 1, 2023 | June 30, 2028 | SIGEL, KEITH MAGNUS | reporter.nih.gov |
| Optimization of lead candidates for an on-demand male contraceptive | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,058,799 | September 21, 2023 | June 30, 2028 | BUCK, JOCHEN | reporter.nih.gov |
| A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors | NIH | National Cancer Institute | 2023 to 2025 | $2,056,218 | July 8, 2023 | June 30, 2028 | HOYT, MICHAEL A | reporter.nih.gov |
| A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC) | NIH | National Cancer Institute | 2023 to 2025 | $2,048,902 | July 7, 2023 | June 30, 2027 | SCHULER, AARON D | reporter.nih.gov |
| 3D Spatial Biology of Prostate Cancer Biopsies For Earlier Identification of High Risk Patients | NIH | National Cancer Institute | 2024 to 2025 | $2,045,816 | September 5, 2020 | June 30, 2027 | REDER, NICHOLAS | reporter.nih.gov |
| Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,041,405 | September 21, 2023 | August 31, 2028 | KIM, HYUNG L | reporter.nih.gov |
| Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial | NIH | National Cancer Institute | 2023 to 2025 | $2,036,734 | September 1, 2023 | August 31, 2028 | COLETTA, ADRIANA | reporter.nih.gov |
| The Role of Sleep in Cardiovascular Health Among Men Living with HIV | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,033,997 | April 20, 2021 | March 31, 2027 | MILLAR, BRETT M | reporter.nih.gov |
| Cellular and molecular mechanisms of vertebrate testis homeostasis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,031,663 | August 1, 2021 | July 31, 2026 | GAGNON, JAMES ALAN | reporter.nih.gov |
| Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | NIH | National Cancer Institute | 2021 to 2025 | $2,021,205 | April 9, 2021 | March 31, 2027 | GIUS, DAVID | reporter.nih.gov |
| Single-Cell Analysis of the Noncoding Genome in Human Diseases and Evolution | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,018,750 | August 13, 2021 | June 30, 2027 | LI, JINGJING | reporter.nih.gov |
| Androgen receptor pathway inhibition through targeting PARP-2 in castration-resistant prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,010,462 | July 1, 2021 | June 30, 2026 | JIA, LI | reporter.nih.gov |
| Specificity of regulatory T cell suppression during infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,009,680 | May 1, 2021 | April 30, 2026 | SAVAGE, PETER AIDAN | reporter.nih.gov |
| Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency | NIH | National Institute on Aging | 2021 to 2025 | $2,009,234 | August 1, 2019 | April 30, 2027 | GARCIA, JOSE M. | reporter.nih.gov |
| Intervention to Help Orient Men to Excel (IN-HOME): A culturally appropriate CHW training program to reduce minority caregiver burden | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $2,008,448 | August 4, 2024 | February 28, 2027 | WANTY, NICOLE I | reporter.nih.gov |
| Functional analysis of novel testis-expressed secreted and transmembrane proteins | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,008,380 | August 1, 2016 | March 31, 2027 | MATZUK, MARTIN M. | reporter.nih.gov |
| Perfluoroalkyl substances and risk of kidney cancer in US men and women | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,005,561 | June 20, 2023 | May 31, 2027 | ZHENG, TONGZHANG | reporter.nih.gov |
| Heterochromatin and Toxic YChromosomes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,002,238 | January 1, 2015 | January 31, 2027 | BACHTROG, DORIS | reporter.nih.gov |
| New roles for Topoisomerase II in meiosis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,000,000 | July 15, 2021 | May 31, 2026 | JARAMILLO-LAMBERT, AIMEE | reporter.nih.gov |
| Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,999,156 | April 1, 2023 | February 28, 2027 | GELFAND, BRADLEY DAVID | reporter.nih.gov |
| Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,996,496 | September 6, 2024 | August 31, 2026 | KAHL, STEPHEN B | reporter.nih.gov |
| Study of AR transcriptional network in stem cell model of SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,988,689 | April 1, 2021 | March 31, 2027 | MIRANDA, HELEN C | reporter.nih.gov |
| Characterizing the binding mechanisms of castration-resistant prostate cancer therapeutics to the intrinsically disordered N-terminal domain of the androgen receptor | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,979,921 | September 15, 2021 | June 30, 2026 | ROBUSTELLI, PAUL | reporter.nih.gov |
| Molecular mechanisms and treatment of cardiomyopathy in Barth Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,974,688 | April 1, 2021 | March 31, 2026 | FANG, XI | reporter.nih.gov |
| Air Pollution and Male-Biased Psychiatric Disorders | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,972,362 | September 18, 2020 | June 30, 2026 | CORY-SLECHTA, DEBORAH A | reporter.nih.gov |
| Molecular regulation and expression of Trop-2 in advanced prostate cancer: Identifying optimal therapeutic niches | NIH | National Cancer Institute | 2023 to 2025 | $1,972,155 | July 1, 2023 | June 30, 2028 | LANG, JOSHUA | reporter.nih.gov |
| Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,971,553 | September 19, 2023 | August 31, 2028 | THOMPSON, TIMOTHY CHARLES | reporter.nih.gov |
| Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs | NIH | National Cancer Institute | 2021 to 2025 | $1,965,536 | June 1, 2021 | May 31, 2026 | BALK, STEVEN P. | reporter.nih.gov |
| Role of Skeletal Muscle Lymphatics in Duchenne Muscular Dystrophy Regulation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,963,162 | May 24, 2022 | April 30, 2027 | MUTHUCHAMY, MARIAPPAN | reporter.nih.gov |
| SCALE: Strategies for Implementing GlobalConsent to Prevent Sexual Violence in University Men | NIH | National Institute of Mental Health | 2023 to 2025 | $1,962,614 | August 1, 2023 | May 31, 2028 | YOUNT, KATHRYN M | reporter.nih.gov |
| Opposing Pathways in Mammalian Sex Determination | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,961,938 | January 1, 1998 | March 31, 2026 | CAPEL, BLANCHE | reporter.nih.gov |
| Systematic evaluation of toxicity and therapeutic efficacy in CD46 directed radioligand therapy | NIH | National Cancer Institute | 2023 to 2025 | $1,959,827 | May 1, 2023 | April 30, 2028 | FLAVELL, ROBERT RICHARD | reporter.nih.gov |
| RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,957,983 | April 29, 2022 | January 31, 2027 | HO, SHUK-MEI | reporter.nih.gov |
| Spermatogonial Stem Cell Establishment and Regulation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,956,978 | May 1, 2016 | June 30, 2026 | WILKINSON, MILES FROME | reporter.nih.gov |
| A novel strategy to overcome drug resistance in cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,956,732 | March 1, 2021 | February 28, 2027 | EDINGER, AIMEE L | reporter.nih.gov |
| Germline Determinants of Prostate Cancer Evolution | NIH | National Cancer Institute | 2023 to 2025 | $1,954,844 | April 1, 2023 | March 31, 2028 | SPELLMAN, PAUL T. | reporter.nih.gov |
| Sex differences in the ability to recover from sleep loss: the roles of development and sex chromosome dosage | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,953,360 | April 1, 2012 | April 30, 2027 | PAUL, KETEMA N | reporter.nih.gov |
| Optimizing prostate cancer care: integrating risks, benefits, and patient experiences in the new era of molecular imaging | NIH | National Cancer Institute | 2023 to 2025 | $1,950,868 | September 13, 2023 | August 31, 2028 | LEAPMAN, MICHAEL STUART | reporter.nih.gov |
| Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,945,498 | September 1, 2022 | August 31, 2027 | FATATIS, ALESSANDRO | reporter.nih.gov |
| Interdependency of fibroadipogenic progenitors and extracellular matrix that drive skeletal muscle fibrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,940,024 | April 5, 2022 | March 31, 2027 | SMITH, LUCAS R | reporter.nih.gov |
| Targeting the colchicine binding site in tubulin for cancer therapy | NIH | National Cancer Institute | 2021 to 2025 | $1,935,287 | January 1, 2011 | December 31, 2026 | LI, WEI | reporter.nih.gov |
| Targeting the microtubule cytoskeleton to promote cavernous nerve regeneration and erectile function after injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,928,183 | September 1, 2023 | June 30, 2028 | DAVIES, KELVIN P | reporter.nih.gov |
| A Digital Twin for Designing Bladder Treatment informed by Bladder Outlet Obstruction Mechanobiology (BOOM) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,925,422 | August 11, 2023 | July 31, 2028 | ROBERTSON, ANNE MARIE | reporter.nih.gov |
| Androgen Signaling in CaP with loss of MAP3K7 and CHD1 | NIH | National Cancer Institute | 2021 to 2025 | $1,924,438 | July 1, 2021 | June 30, 2026 | CRAMER, SCOTT D | reporter.nih.gov |
| Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,922,720 | April 12, 2023 | March 31, 2028 | KIBEL, ADAM S | reporter.nih.gov |
| "DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer" | NIH | National Cancer Institute | 2023 to 2025 | $1,921,654 | June 1, 2023 | May 31, 2028 | RICKMAN, DAVID S. | reporter.nih.gov |
| Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,917,613 | May 8, 2019 | April 30, 2027 | GARCIA, JOSE M. | reporter.nih.gov |
| Investigating a novel role of ejaculate RNA in fertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,915,474 | August 18, 2023 | May 31, 2027 | MATZKIN, LUCIANO MATIAS | reporter.nih.gov |
| Actions of Seminal Proteins in Mated Drosophila Females | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,914,332 | July 1, 2025 | June 30, 2030 | WOLFNER, MARIANA FEDERICA | reporter.nih.gov |
| Drug Development of Skp2 PROTACs in Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,912,388 | May 31, 2023 | April 30, 2028 | LI, HONG-YU | reporter.nih.gov |
| AR Gene Rearrangements and AR Signaling in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,909,771 | April 1, 2013 | March 31, 2028 | DEHM, SCOTT M. | reporter.nih.gov |
| Ligand-mediated, vehicle-free delivery of small RNAs | NIH | National Cancer Institute | 2021 to 2025 | $1,908,192 | April 1, 2018 | August 31, 2028 | KASINSKI, ANDREA L | reporter.nih.gov |
| Deciphering Mechanisms of Tumor-Stromal Interactions in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,908,093 | May 1, 2021 | April 30, 2027 | WU, BOYANG | reporter.nih.gov |
| Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,907,212 | September 20, 2022 | June 30, 2027 | MARTYNYUK, ANATOLY E | reporter.nih.gov |
| Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation | NIH | National Cancer Institute | 2021 to 2025 | $1,906,181 | April 1, 2021 | March 31, 2027 | CHAISWING, LUKSANA | reporter.nih.gov |
| Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,900,860 | April 1, 2021 | March 31, 2027 | DASGUPTA, SUBHAMOY | reporter.nih.gov |
| "Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis" | NIH | National Cancer Institute | 2023 to 2025 | $1,899,979 | April 1, 2023 | March 31, 2028 | NOWAK, DAWID GRZEGORZ | reporter.nih.gov |
| Effects of TNF Blockade on Human BPH/LUTS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,899,179 | August 15, 2023 | May 31, 2028 | HAYWARD, SIMON W | reporter.nih.gov |
| Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,894,111 | August 13, 2021 | July 31, 2026 | COHN, BARBARA A | reporter.nih.gov |
| Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers | NIH | National Cancer Institute | 2021 to 2025 | $1,887,170 | September 20, 2016 | August 31, 2026 | ZHENG, LI | reporter.nih.gov |
| Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,886,508 | February 5, 2024 | March 31, 2027 | BROGAARD, KRISTIN R | reporter.nih.gov |
| Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,884,679 | September 15, 2023 | August 31, 2028 | SUNG, KYUNG HYUN | reporter.nih.gov |
| Inside-Out Nonlinear Gradients to Improve Diffusion MRI | NIH | National Cancer Institute | 2021 to 2025 | $1,881,297 | July 6, 2021 | September 30, 2026 | GALIANA, GIGI | reporter.nih.gov |
| Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC) | NIH | National Cancer Institute | 2023 to 2025 | $1,877,904 | September 21, 2023 | August 31, 2028 | APARICIO, ANA | reporter.nih.gov |
| Statistical methods for genomic analysis of heterogeneous tumors | NIH | National Cancer Institute | 2022 to 2025 | $1,872,847 | July 8, 2022 | June 30, 2027 | WANG, WENYI | reporter.nih.gov |
| Therapeutic targeting Wnt5A signaling for advanced prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,872,645 | December 1, 2020 | November 30, 2026 | GAO, ALLEN C. | reporter.nih.gov |
| Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,869,903 | April 1, 2021 | March 31, 2026 | BATTISTONE, MARIA AGUSTINA | reporter.nih.gov |
| Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,867,088 | July 1, 2023 | June 30, 2028 | LIU, XIAOQI | reporter.nih.gov |
| Drug Eluting Silk Fibroin Grafts for Repair of Long Urethral Strictures | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,864,246 | February 15, 2023 | December 31, 2026 | MAUNEY, JOSHUA ROBERT | reporter.nih.gov |
| Intraflagellar transport (IFT) and sperm formation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,864,073 | April 1, 2022 | January 31, 2027 | ZHANG, ZHIBING | reporter.nih.gov |
| Transgenerational epigenetic regulation by Rlim | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,860,934 | June 1, 2022 | February 28, 2027 | BACH, INGOLF M | reporter.nih.gov |
| Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients | NIH | National Cancer Institute | 2023 to 2025 | $1,856,603 | February 1, 2023 | August 31, 2028 | HOLLENBECK, BRENT K. | reporter.nih.gov |
| The Clinical History of Rectal and Urethral STIs among MSM: characterizing microbiome host immune interactions for diagnostic and vaccine advances | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,855,034 | August 1, 2025 | July 31, 2028 | MEHTA, SUPRIYA DINESH | reporter.nih.gov |
| Deciphering the roles of FXR1 in health and myopathy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,854,831 | August 1, 2022 | July 31, 2026 | GREGORIO, CAROL C | reporter.nih.gov |
| Population genomics in laboratory and outbred mouse populations | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,852,995 | August 1, 2019 | January 31, 2030 | DUMONT, BETHANY L | reporter.nih.gov |
| In vivo biology of mammalian L1 retrotransposition | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,849,925 | January 12, 2022 | December 31, 2026 | HAN, JEFFREY S | reporter.nih.gov |
| Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators | NIH | National Cancer Institute | 2023 to 2025 | $1,846,447 | February 7, 2023 | January 31, 2028 | KELLEY, SHANA O | reporter.nih.gov |
| Addressing Circulation of Guideline-Discordant Information to Promote Optimal Prostate Cancer Care | NIH | National Cancer Institute | 2023 to 2025 | $1,837,936 | February 7, 2023 | January 31, 2028 | LOEB, STACY | reporter.nih.gov |
| High-throughput Clinical Hyperpolarized 13C MRI | NIH | Office of the Director, National Institutes of Health | 2025 | $1,835,840 | August 1, 2025 | July 1, 2027 | TSAI, LEO LEE | reporter.nih.gov |
| Social network disruption, stigma, and HIV transmission and care dynamics among forcibly displaced MSM in Ukraine | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,833,440 | November 1, 2023 | June 30, 2028 | VASYLYEVA, TETYANA | reporter.nih.gov |
| Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV. | NIH | National Institute on Drug Abuse | 2025 | $1,828,735 | May 15, 2023 | April 30, 2028 | SPINELLI, MATTHEW A. | reporter.nih.gov |
| Elevated homocysteine in African American Prostate Cancer: Association with Diet and Dietary practices, evaluating its biomarker potential, and characterizing its tumor promoting function | NIH | National Cancer Institute | 2022 to 2025 | $1,824,802 | April 1, 2022 | March 31, 2027 | SREEKUMAR, ARUN | reporter.nih.gov |
| Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches | NIH | National Cancer Institute | 2023 to 2025 | $1,823,701 | July 7, 2023 | June 30, 2028 | IPPOLITO, JOSEPH EDWARD | reporter.nih.gov |
| Retinal structure, function and response to gene therapy | NIH | National Eye Institute | 2021 to 2025 | $1,823,500 | March 1, 2018 | February 28, 2029 | MORGAN, JESSICA I.W. | reporter.nih.gov |
| Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,819,525 | June 4, 2021 | November 30, 2026 | SONG, MIN SUP | reporter.nih.gov |
| Diversification of cell types during male and female external genital development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,815,494 | September 30, 2021 | July 31, 2026 | COHN, MARTIN J | reporter.nih.gov |
| Examining a Multicomponent Intervention to Improve HIV Health among Black Men in Southern Ending the HIV Epidemic in the U.S. Jurisdictions | NIH | National Institute of Mental Health | 2023 to 2025 | $1,812,263 | August 1, 2023 | May 31, 2028 | ENGLISH, DEVIN | reporter.nih.gov |
| Testing the Efficacy of Safe South Africa: An Intervention to Prevent HIV Risk and Interpersonal Violence Among Adolescent Boys | NIH | National Institute of Mental Health | 2023 to 2025 | $1,801,635 | July 1, 2023 | April 30, 2028 | KUO, CAROLINE CHIA | reporter.nih.gov |
| Assessing Photoreceptor Structure and Function in Normal and Diseased Retinae | NIH | National Eye Institute | 2023 to 2025 | $1,801,350 | August 15, 2008 | June 30, 2027 | CARROLL, JOSEPH | reporter.nih.gov |
| Development of Methods for a Simplified and Reliable Prostate Cancer MRI Exam | NIH | National Cancer Institute | 2021 to 2025 | $1,799,393 | June 1, 2020 | November 30, 2026 | MAIER, STEPHAN E | reporter.nih.gov |
| Adaptive Percutaneous Prostate Interventions using Sensorized Needle | NIH | National Cancer Institute | 2021 to 2025 | $1,799,242 | August 1, 2019 | February 29, 2028 | TOKUDA, JUNICHI | reporter.nih.gov |
| The Role of Lipin1 in Myofiber Stability and Integrity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,799,008 | July 22, 2021 | May 31, 2027 | REN, HONGMEI | reporter.nih.gov |
| Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,796,578 | January 1, 2019 | April 30, 2027 | JOHNSON, JEREMY JAMES | reporter.nih.gov |
| Ethics of HIV-related research involving underage key populations in sub-Saharan Africa | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,791,360 | September 20, 2022 | June 30, 2027 | GROSSO, ASHLEY LYNN | reporter.nih.gov |
| Stromal Foxf2 suppresses prostate cancer progression | NIH | National Cancer Institute | 2022 to 2025 | $1,790,773 | July 1, 2022 | May 31, 2027 | XIN, LI | reporter.nih.gov |
| The genome integrity and epigenome of sperm from men with recurrent pregnancy loss | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,789,021 | July 1, 2023 | March 31, 2028 | MAK, WINIFRED W | reporter.nih.gov |
| Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population | NIH | National Cancer Institute | 2023 to 2025 | $1,787,388 | August 1, 2023 | July 31, 2028 | LANGSTON, MARVIN EPOLIAN | reporter.nih.gov |
| Controllable base editing therapy for DMD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,786,579 | September 1, 2023 | August 31, 2027 | HAN, RENZHI | reporter.nih.gov |
| Modulating HSP70/STUB1 machinery in therapy-resistant prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,783,175 | September 1, 2021 | August 31, 2026 | LIU, CHENGFEI | reporter.nih.gov |
| Sex Differences in Postprandial Lipid Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,779,370 | July 20, 2022 | May 31, 2027 | REUE, KAREN | reporter.nih.gov |
| Dissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,770,550 | July 1, 2021 | June 30, 2026 | LIU, CHENGFEI | reporter.nih.gov |
| A novel AR degrader in castrate-resistant prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,765,881 | August 15, 2023 | June 30, 2028 | KIM, HYEONG-REH CHOI | reporter.nih.gov |
| In vivo hematopoietic stem cell genetic modification by viral particles | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,764,905 | September 9, 2024 | May 31, 2028 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes | NIH | National Cancer Institute | 2023 to 2025 | $1,755,220 | September 19, 2023 | August 31, 2028 | HA, GAVIN | reporter.nih.gov |
| Ethical Multimodal fusion Artificial Intelligence platform (EMAP) to bridge the gap between imaging modalities: Application to prostate cancer diagnosis. | NIH | Office of the Director, National Institutes of Health | 2025 | $1,753,477 | September 15, 2025 | September 14, 2026 | RUSU, MIRABELA | reporter.nih.gov |
| Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells | NIH | National Cancer Institute | 2021 to 2025 | $1,753,253 | June 1, 2019 | March 31, 2030 | TANG, DEAN G. | reporter.nih.gov |
| Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,751,600 | December 25, 2021 | November 30, 2026 | XIE, LAI-HUA | reporter.nih.gov |
| Reducing Hypertension among African American Men: A Mobile Stress Management Intervention to Address Health Disparities | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,750,751 | September 18, 2021 | May 31, 2027 | LEAF, SAMANTHA L. | reporter.nih.gov |
| Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy | NIH | National Cancer Institute | 2022 to 2025 | $1,749,738 | July 1, 2022 | June 30, 2027 | LI, ZHIGUO | reporter.nih.gov |
| Targeting allosteric scaffolding functions of Aurora kinase A in cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,740,140 | April 1, 2021 | March 31, 2027 | LEVINSON, NICHOLAS MARK | reporter.nih.gov |
| A dyadic exercise approach to prevent declines in physical and mental health in couples during radiation treatment for cancer: a hybrid type I efficacy-implementation trial | NIH | National Cancer Institute | 2023 to 2025 | $1,737,544 | July 1, 2023 | June 30, 2028 | WINTERS-STONE, KERRI M | reporter.nih.gov |
| Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,734,793 | January 1, 2023 | December 31, 2027 | ZHAO, DI | reporter.nih.gov |
| RET Regulation and Targeting in Neuroendocrine Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,732,079 | May 1, 2022 | April 30, 2027 | DRAKE, JUSTIN MICHAEL | reporter.nih.gov |
| Leveraging PMN immune response to overcome ADT resistance in bone metastatic prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,731,077 | September 1, 2022 | August 31, 2027 | MATHEW, GRINU | reporter.nih.gov |
| Mechanisms of mineralocorticoid receptor antagonism on inflammation in muscular dystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,726,538 | January 1, 2022 | December 31, 2026 | RAFAEL-FORTNEY, JILL A | reporter.nih.gov |
| MAOA and AR Reciprocal Crosstalk in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,725,441 | January 1, 2019 | December 31, 2025 | WU, BOYANG | reporter.nih.gov |
| Mechanisms of sodium channel clustering at the neuromuscular junction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,723,360 | January 20, 2020 | December 31, 2029 | RASBAND, MATTHEW N | reporter.nih.gov |
| Parp Function in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,722,423 | March 1, 2017 | February 29, 2028 | PASCHAL, BRYCE | reporter.nih.gov |
| Enteric glia and visceral pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,715,750 | March 1, 2024 | February 28, 2028 | GULBRANSEN, BRIAN D. | reporter.nih.gov |
| A preconception cohort study of air pollution, fertility, and miscarriage | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,711,178 | July 1, 2018 | March 31, 2030 | WESSELINK, AMELIA KENT | reporter.nih.gov |
| Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $1,708,848 | December 15, 2017 | January 31, 2028 | EXNER, AGATA A | reporter.nih.gov |
| The Impact of Aging on Prostate Cancer with Age-Related Disruption of Th17/Treg Axis | NIH | National Cancer Institute | 2021 to 2025 | $1,707,208 | January 1, 2021 | December 31, 2026 | ZHANG, QIUYANG | reporter.nih.gov |
| Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE) | NIH | National Cancer Institute | 2023 to 2025 | $1,705,585 | June 22, 2023 | May 31, 2028 | WINTERS-STONE, KERRI M | reporter.nih.gov |
| Perinatal Gonadal Hormones Impart Male-Biased Neuroimmune, Mitochondrial, and Behavioral Vulnerabilities. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,698,345 | September 1, 2023 | May 31, 2028 | BORDT, EVAN ANDREW | reporter.nih.gov |
| Restoring Ocrl1 function in Lowe Syndrome and Dent-2 disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,697,585 | September 20, 2021 | June 30, 2027 | AGUILAR, RUBEN CLAUDIO | reporter.nih.gov |
| Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,694,079 | September 23, 2023 | August 31, 2027 | WEISLEDER, NOAH | reporter.nih.gov |
| Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,690,924 | February 3, 2022 | June 30, 2027 | DOMINGO-DOMENECH, JOSEP MARIA | reporter.nih.gov |
| The role of the female and male reproductive microenvironment in fertility fitness | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,689,063 | August 1, 2023 | April 30, 2028 | FARR ZUEND, CHRISTINA | reporter.nih.gov |
| Sacral neuromodulation for the management of chronic pelvic pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,689,002 | September 20, 2023 | July 31, 2028 | PETERS, KENNETH M | reporter.nih.gov |
| Molecular basis of fatty acid transport by peroxisomal ABC transporters | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,686,482 | September 10, 2022 | July 31, 2027 | ALAM, AMER | reporter.nih.gov |
| Multidimensional analyses to improve PSMA-RPT efficacy in mCRPC | NIH | National Cancer Institute | 2023 to 2025 | $1,679,715 | July 12, 2023 | March 31, 2028 | CZERNIN, JOHANNES | reporter.nih.gov |
| Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy | NIH | National Cancer Institute | 2021 to 2025 | $1,668,272 | January 1, 2021 | December 31, 2025 | PLATZ, ELIZABETH A. | reporter.nih.gov |
| Functions of skeletal muscle mineralocorticoid receptor signaling in chronic and acute injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,666,931 | April 1, 2018 | August 31, 2029 | RAFAEL-FORTNEY, JILL A | reporter.nih.gov |
| The telomere biomarker as a tool to inform decision-making for aggressive salvage therapy in men with rising PSA post prostatectomy | NIH | National Cancer Institute | 2023 to 2025 | $1,663,456 | August 22, 2023 | July 31, 2027 | MEEKER, ALAN KEITH | reporter.nih.gov |
| Mechanisms of contractile dysfunction in the obstructed bladder: Role of desmin and vimentin | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,656,768 | September 15, 2022 | May 31, 2027 | ETTICKAN, BOOPATHI | reporter.nih.gov |
| Targeting chemoresistant prostate cancer with novel EED inhibitors | NIH | National Cancer Institute | 2022 to 2025 | $1,655,250 | April 1, 2022 | March 31, 2028 | WU, DAQING | reporter.nih.gov |
| Reducing hazardous alcohol use and optimizing treatment as prevention among men living with HIV in risk environments | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $1,652,598 | August 1, 2024 | July 31, 2029 | KIENE, SUSAN MARIA | reporter.nih.gov |
| 3D Bioprinted Human Model of Duchenne Muscular Dystrophy (DMD) Cardiomyopathy to Study Disease Progression with Imposed Force and Precise Gene Editing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,651,448 | July 1, 2023 | April 30, 2028 | KAMDAR, FORUM D | reporter.nih.gov |
| Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,651,150 | April 1, 2022 | March 31, 2027 | CHEN, MING | reporter.nih.gov |
| CRISPR editing therapy for Duchenne muscular dystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,639,600 | July 15, 2023 | June 30, 2028 | DUAN, DONGSHENG | reporter.nih.gov |
| Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology | NIH | National Cancer Institute | 2022 to 2025 | $1,637,004 | March 1, 2022 | February 28, 2027 | CHEN, MING | reporter.nih.gov |
| Defining WASp-dependent pathways in replication stress | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,636,788 | August 7, 2023 | July 31, 2026 | VYAS, YATIN M | reporter.nih.gov |
| Organizing and Reorganizing Human Testis Development In Vitro | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,634,435 | September 22, 2023 | June 30, 2028 | ORWIG, KYLE EDWIN | reporter.nih.gov |
| Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers | NIH | National Cancer Institute | 2023 to 2025 | $1,633,514 | August 10, 2023 | July 31, 2028 | ADELAIYE-OGALA, REMI | reporter.nih.gov |
| The Genomic Basis and Molecular Mechanisms of Speciation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,626,403 | September 19, 2022 | July 31, 2027 | AHMED-BRAIMAH, YASIR | reporter.nih.gov |
| Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,621,817 | August 1, 2023 | July 31, 2028 | DIAZ MECO CONDE, MARIA TERESA | reporter.nih.gov |
| Genetic and molecular architecture of sex-specific drug response in human islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,616,241 | April 15, 2007 | June 30, 2028 | MAUVAIS-JARVIS, FRANCK | reporter.nih.gov |
| Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers | NIH | National Cancer Institute | 2022 to 2025 | $1,612,380 | September 22, 2022 | August 31, 2027 | EASTHAM, JAMES A | reporter.nih.gov |
| Improving chemotherapy of castration-resistant prostate cancer. | NIH | National Cancer Institute | 2021 to 2025 | $1,603,204 | August 10, 2016 | June 30, 2026 | LIU, XIAOQI | reporter.nih.gov |
| The Bridge Clinic: Optimizing Injectable PrEP Delivery for Transgender and Non-Binary People | NIH | National Institute of Mental Health | 2023 to 2025 | $1,597,883 | April 1, 2023 | January 31, 2028 | LIU, ALBERT YING-HWA | reporter.nih.gov |
| A novel determinant of prostate cancer growth | NIH | National Cancer Institute | 2021 to 2025 | $1,596,877 | April 1, 2021 | March 31, 2026 | HEEMERS, HANNELORE | reporter.nih.gov |
| Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,595,053 | August 14, 2024 | October 31, 2029 | SPINELLI, MATTHEW A. | reporter.nih.gov |
| Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men | NIH | National Cancer Institute | 2023 to 2025 | $1,586,636 | May 1, 2023 | April 30, 2028 | LIU, XUEFENG | reporter.nih.gov |
| Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity | NIH | National Cancer Institute | 2022 to 2025 | $1,582,219 | July 1, 2022 | June 30, 2027 | NELSON, PETER S | reporter.nih.gov |
| Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,582,016 | August 1, 2024 | June 30, 2026 | FATEMI, S. ALI | reporter.nih.gov |
| Rise & Thrive: Community-Engagement Intervention to Address Chronic Stress and Prevent Depression in Adolescents and Young Adults | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,577,181 | May 17, 2024 | December 31, 2028 | HEARD-GARRIS, NIA JENEE' | reporter.nih.gov |
| Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,576,689 | January 23, 2024 | December 31, 2028 | SOSLOW, JONATHAN HARVEY | reporter.nih.gov |
| Differential activation of the triacylglycerol pathway in lipofibroblasts induces neurogenesis associated with prostate cancer progression | NIH | National Cancer Institute | 2025 | $1,575,170 | September 12, 2025 | July 31, 2029 | FRANCO CORONEL, OMAR | reporter.nih.gov |
| Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,561,820 | August 16, 2023 | February 29, 2028 | ZEIGLER-JOHNSON, CHARNITA M. | reporter.nih.gov |
| Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,559,533 | September 25, 2023 | July 31, 2027 | KYBA, MICHAEL | reporter.nih.gov |
| Investigating the molecular functions and mechanisms of RNA-binding proteins crucial for gametogenesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,551,531 | June 1, 2022 | May 31, 2027 | FUKUNAGA, RYUYA | reporter.nih.gov |
| Developmental programming of stress-sensitive neural circuits underlying social behavior | NIH | National Institute of Mental Health | 2024 to 2025 | $1,546,376 | April 22, 2024 | January 31, 2029 | TRAINOR, BRIAN C | reporter.nih.gov |
| Robot-Assisted Personalized Prostate Biopsy | NIH | National Cancer Institute | 2021 to 2025 | $1,543,611 | April 1, 2021 | March 31, 2027 | STOIANOVICI, DAN | reporter.nih.gov |
| Hormone signaling and translation control in advanced prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,542,779 | December 1, 2023 | November 30, 2025 | HSIEH, ANDREW CALEB | reporter.nih.gov |
| Molecular sensors for metabolic programming of the sperm epigenome and offspring physiology | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,541,725 | April 15, 2021 | March 31, 2027 | MEYER-FICCA, MIRELLA L | reporter.nih.gov |
| Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,535,622 | August 1, 2022 | July 31, 2027 | CHEN, MING | reporter.nih.gov |
| A seek, test, and treat intervention to reduce Chlamydia trachomatis disparities in youth living in the deep South | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,529,531 | July 1, 2024 | May 31, 2029 | KISSINGER, PATRICIA J | reporter.nih.gov |
| Targeting MED31-driven transcription recycling in lethal prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,523,960 | July 1, 2023 | June 30, 2028 | HE, YIPING | reporter.nih.gov |
| Role of E-Cadherin Down-Regulation in Prostatic Inflammation and Lower Urinary Tract Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,523,140 | March 1, 2023 | February 28, 2027 | WANG, ZHOU | reporter.nih.gov |
| Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance | NIH | National Cancer Institute | 2023 to 2025 | $1,522,620 | January 3, 2022 | August 31, 2027 | LIN, HUI-KUAN | reporter.nih.gov |
| FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A | NIH | National Cancer Institute | 2023 to 2025 | $1,517,182 | August 1, 2023 | July 31, 2028 | YU, JINDAN | reporter.nih.gov |
| Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response | NIH | National Cancer Institute | 2022 to 2025 | $1,515,269 | December 1, 2021 | November 30, 2027 | KACHHAP, SUSHANT KRISHNA | reporter.nih.gov |
| Development of early metabolic imaging biomarkers for muscular dystrophy and cardiomyopathy in patients | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,514,698 | June 15, 2024 | April 30, 2028 | PARK, JAE MO | reporter.nih.gov |
| Mechanisms of sperm chromatin remodeling in vivo and in vitro | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,511,208 | August 15, 2023 | May 31, 2027 | HAMMOUD, SAHER SUE | reporter.nih.gov |
| The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection | NIH | National Cancer Institute | 2023 to 2025 | $1,497,955 | July 12, 2023 | June 30, 2028 | PUNNEN, SANOJ | reporter.nih.gov |
| Gene Editing for Hemophilia A Treatment Using Lipid Nanoparticles | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,492,583 | August 15, 2024 | May 31, 2028 | MIAO, CAROL H | reporter.nih.gov |
| Rare sperm screening and retrieval with a domain-adaptive deep learning-enabled microwell system. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,485,932 | August 15, 2024 | April 30, 2029 | SHAFIEE, HADI | reporter.nih.gov |
| Hormonal Regulation Sertoli Cell Maturation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,479,590 | August 1, 1977 | March 31, 2029 | GRISWOLD, MICHAEL D | reporter.nih.gov |
| Network-based study design, statistical, and modeling solutions for HIV among populations that use illicit substances: Informing interventions and policy in real-world settings using existing data | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,474,543 | September 15, 2024 | July 31, 2029 | BUCHANAN, ASHLEY LYNN | reporter.nih.gov |
| Mitochondrial dynamics in spermatogonial differentiation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,471,762 | September 1, 2022 | July 31, 2027 | WANG, YUAN | reporter.nih.gov |
| Targeting androgen receptor nuclear localization in prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,471,591 | June 10, 2022 | May 31, 2027 | WANG, ZHOU | reporter.nih.gov |
| Multimodal, Multi-scale Framework for Ethical AI Model Development | NIH | Office of the Director, National Institutes of Health | 2025 | $1,464,652 | June 30, 2025 | June 29, 2027 | GICHOYA, JUDY | reporter.nih.gov |
| Optimizing a Just-in-Time Adaptive Intervention to Increase Uptake of Chemsex Harm Reduction Services in MSM: A Micro-randomized Trial | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,457,846 | July 15, 2024 | April 30, 2029 | SHRESTHA, ROMAN | reporter.nih.gov |
| Selecting sperm with distinct metabolic phenotypes to increase ART efficiency | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,456,211 | April 19, 2023 | March 31, 2027 | GEYER, CHRISTOPHER BENNETT | reporter.nih.gov |
| Glutaminase I isoforms as personalized biomarkers of prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,452,662 | January 1, 2022 | December 31, 2026 | HUANG, JIAOTI | reporter.nih.gov |
| Characterizing Intersectional Geospatial Stigma and Affirmation Landscapes and Their Influence on Black and Latino Bisexual Men At Risk for Substance Abuse and HIV | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,443,905 | July 15, 2024 | August 31, 2029 | XAVIER HALL, CASEY DANIEL | reporter.nih.gov |
| Automated Assessment for Robotic Suturing Utilizing Deep Learning Algorithms | NIH | National Cancer Institute | 2023 to 2025 | $1,438,983 | April 1, 2021 | March 31, 2026 | HUNG, ANDREW | reporter.nih.gov |
| Social Networks and Cognitive Health among Black and Latino sexual minority men in NJ | NIH | National Institute on Aging | 2024 to 2025 | $1,437,209 | September 23, 2024 | August 31, 2029 | YANG, CUI | reporter.nih.gov |
| Targeting aberrant circadian regulator in advanced prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,436,443 | December 15, 2021 | November 30, 2026 | CHEN, HONGWU | reporter.nih.gov |
| Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis | NIH | National Cancer Institute | 2022 to 2025 | $1,433,646 | March 1, 2022 | February 28, 2028 | WANG, LIEWEI | reporter.nih.gov |
| Transgenerational epigenetic programming of the thyroid axis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,432,000 | July 16, 2012 | May 31, 2029 | HERNANDEZ, ARTURO | reporter.nih.gov |
| COP1 REGULATION OF AR SIGNALING AND PROSTATE CANCER GROWTH AND THERAPY RESISTANCE | NIH | National Cancer Institute | 2023 to 2025 | $1,431,666 | May 1, 2023 | April 30, 2028 | YANG, FENG | reporter.nih.gov |
| Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,430,854 | July 1, 2024 | June 30, 2028 | KAGAN, VALERIAN E | reporter.nih.gov |
| Targeting a Novel Signaling Nexus pACK/pCSK/pLCK in Immune Checkpoint Blockade (ICB)-Resistant Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,428,877 | July 1, 2023 | June 30, 2028 | MAHAJAN, NUPAM P | reporter.nih.gov |
| Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,422,658 | December 9, 2021 | November 30, 2026 | ZI, XIAOLIN | reporter.nih.gov |
| Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,421,960 | August 1, 2024 | July 31, 2029 | ZHOU, PENGBO | reporter.nih.gov |
| Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,419,727 | September 4, 2024 | August 31, 2029 | PONOMAREV, VLADIMIR | reporter.nih.gov |
| Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate | NIH | National Cancer Institute | 2024 to 2025 | $1,419,480 | July 2, 2024 | June 30, 2028 | BODEI, LISA | reporter.nih.gov |
| Epigenetic aging as a driver of racial disparities in early onset prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,416,138 | September 20, 2024 | August 31, 2029 | WOLOSZYNSKA-READ, ANNA | reporter.nih.gov |
| The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $1,404,849 | September 19, 2023 | August 31, 2027 | RO, JIN Y | reporter.nih.gov |
| Comprehensive Analyses of HOXB13-regulated Transcriptional programs critical for Prostate Cancer Progression | NIH | National Cancer Institute | 2023 to 2025 | $1,398,942 | March 1, 2023 | February 28, 2026 | YU, JINDAN | reporter.nih.gov |
| ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,397,432 | April 1, 2024 | March 31, 2029 | MCCLURE, TIMOTHY | reporter.nih.gov |
| Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,396,513 | August 1, 2022 | July 31, 2027 | LI, WENLIANG | reporter.nih.gov |
| Understanding the Mechanisms of Fibrosis in Muscular Dystrophies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,392,499 | July 12, 2023 | May 31, 2028 | HAMMERS, DAVID W | reporter.nih.gov |
| Connexin 43: a new player in Duchenne muscular dystrophy associated cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,392,382 | July 15, 2024 | May 31, 2028 | FRAIDENRAICH, DIEGO | reporter.nih.gov |
| Examining the Mechanisms and Consequences of Poor Sleep Health Among Black Gay Men | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,390,601 | August 2, 2024 | February 28, 2029 | DONG, LU | reporter.nih.gov |
| Macrocycle inhibition of beta-catenin mediated transcription in prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,388,993 | June 1, 2024 | May 31, 2026 | LOGAN, SUSAN K. | reporter.nih.gov |
| Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy | NIH | National Cancer Institute | 2024 to 2025 | $1,388,233 | February 1, 2024 | January 31, 2029 | HAFFNER, MICHAEL C | reporter.nih.gov |
| Substance Misuse and Family Violence Treatment for Fathers | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,387,445 | August 1, 2024 | May 31, 2029 | STOVER, CARLA S | reporter.nih.gov |
| Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners | NIH | National Cancer Institute | 2023 to 2025 | $1,387,108 | June 21, 2022 | March 31, 2027 | CRUMP, CASEY | reporter.nih.gov |
| Intervention to improve parent communication about sexuality | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,384,023 | September 16, 2024 | August 31, 2029 | FLORES, DALMACIO DENNIS | reporter.nih.gov |
| Targeting early events in prostate cancer lineage plasticity | NIH | National Cancer Institute | 2023 to 2025 | $1,380,656 | December 1, 2022 | November 30, 2027 | DEHM, SCOTT M. | reporter.nih.gov |
| Racial Difference in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,380,415 | April 1, 2018 | December 31, 2029 | FREEMAN, MICHAEL R. | reporter.nih.gov |
| Regulation of Mitochondrial Metabolism by Tyr-phosphorylated ATP Synthase Alpha-Subunit and its Therapeutic Implications in Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,379,959 | April 1, 2023 | March 31, 2028 | MAHAJAN, NUPAM P | reporter.nih.gov |
| Novel mechanisms regulating translation elongation during male germ cell differentiation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,376,190 | July 15, 2022 | March 31, 2027 | SNYDER, ELIZABETH M, | reporter.nih.gov |
| Development of ADAM Air: A Non-Hormonal Vas Occlusive Contraceptive Device | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,368,556 | September 10, 2024 | August 31, 2027 | TROPSHA, YELENA | reporter.nih.gov |
| Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,367,760 | September 19, 2024 | August 31, 2029 | POMPER, MARTIN G | reporter.nih.gov |
| The Role of Chibby Family Members in Spermatogenesis and Male Fertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,365,962 | September 1, 2024 | August 31, 2026 | TAKEMARU, KEN-ICHI | reporter.nih.gov |
| Orally active CBP/p300 degraders | NIH | National Cancer Institute | 2024 to 2025 | $1,361,184 | March 1, 2024 | February 28, 2029 | WANG, SHAOMENG | reporter.nih.gov |
| Mechanisms of voltage regulation of membrane transport | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,360,480 | April 1, 2022 | February 28, 2027 | CHOWDHURY, SANDIPAN | reporter.nih.gov |
| Omic Approaches to Factor VIII Inhibitor Development in Hemophilia Patients of Mexican Descent | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,359,211 | September 1, 2024 | June 30, 2028 | HOWARD, TOM EUGENE | reporter.nih.gov |
| A Multi-Level Integrated Strategy to Optimize PrEP Adherence and Accelerate Implementation at Scale | NIH | National Institute of Mental Health | 2024 to 2025 | $1,356,610 | September 6, 2024 | June 30, 2029 | RAMOS, SILVIA RAQUEL | reporter.nih.gov |
| A type I hybrid effectiveness-implementation study of a parent-centered tool to promote shared decision-making in hypospadias care | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,355,812 | August 22, 2024 | June 30, 2029 | SCHILLING, SAMANTHA S | reporter.nih.gov |
| Skeletal Muscle Fibrosis and Progesterone Receptor | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,355,374 | May 1, 2024 | April 30, 2028 | BULUN, SERDAR E. | reporter.nih.gov |
| Quantitative MRI to automatically delineate intraprostatic tumor for radiation therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,353,393 | July 1, 2024 | June 30, 2029 | QING, KUN | reporter.nih.gov |
| In-Vivo Monitoring of Therapeutic Drug Transport Across Biological Barriers | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,350,201 | September 1, 2021 | September 2, 2025 | ARROYO CURRAS, NETZAHUALCOYOTL | reporter.nih.gov |
| Pelvic ganglia inflammation as a factor leading to organ crosstalk and coordinated development of bladder and erectile dysfunction following pelvic surgery. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,350,180 | April 15, 2024 | January 31, 2029 | DAVIES, KELVIN P | reporter.nih.gov |
| Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,348,066 | July 3, 2023 | June 30, 2028 | ZARIF, JELANI CHINELO | reporter.nih.gov |
| Delineate the Role of GSTP1 in Advanced Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,346,711 | July 14, 2023 | May 31, 2028 | STOYANOVA, TANYA I | reporter.nih.gov |
| Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance | NIH | National Cancer Institute | 2024 to 2025 | $1,344,370 | May 1, 2024 | April 30, 2029 | HUANG, JIAOTI | reporter.nih.gov |
| Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas | NIH | National Cancer Institute | 2024 to 2025 | $1,341,635 | May 1, 2024 | April 30, 2029 | VAKOC, CHRISTOPHER | reporter.nih.gov |
| Molecular Mechanisms of Dystrophin Expression in Ameliorated Phenotypes | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,340,252 | January 18, 2023 | December 31, 2027 | FLANIGAN, KEVIN M | reporter.nih.gov |
| Localized SDF-1 mRNA nanoparticle delivery for treating erectile dysfunction. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,338,910 | May 1, 2022 | April 30, 2027 | SUK, JUNG SOO | reporter.nih.gov |
| Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,338,069 | April 1, 2023 | March 31, 2028 | DICKSON, PATRICIA I | reporter.nih.gov |
| Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach | NIH | National Institute of Mental Health | 2024 to 2025 | $1,333,100 | September 16, 2024 | March 31, 2029 | SMITH, M KUMI | reporter.nih.gov |
| Sperm mitochondrial biomarkers and male reproductive health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,330,848 | February 20, 2024 | January 31, 2029 | PILSNER, J. RICHARD | reporter.nih.gov |
| Regulation of prostate epithelial basal cell plasticity | NIH | National Cancer Institute | 2022 to 2025 | $1,329,440 | September 25, 2015 | February 28, 2027 | WANG, ZHU | reporter.nih.gov |
| Strategies to Prevent HIV Acquisition for At-Risk Men in the US | NIH | National Institute of Mental Health | 2024 to 2025 | $1,328,950 | May 15, 2024 | October 31, 2027 | REISNER, SARI | reporter.nih.gov |
| Ciliary Hedgehog signaling during adult tissue repair and disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,327,925 | April 1, 2022 | March 31, 2027 | KOPINKE, DANIEL | reporter.nih.gov |
| Site-randomized Trial of a Novel Social Network Recruitment Intervention to Locate More Undiagnosed Positive Cases of HIV, Increase HIV Testing among Men, and Reduce HIV-related Stigma in South Africa | NIH | National Institute of Mental Health | 2024 to 2025 | $1,326,478 | July 15, 2024 | April 30, 2029 | WILLIAMS, LESLIE DENISE | reporter.nih.gov |
| A novel role for EZH2 in A-to-I RNA editing in prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,325,538 | February 5, 2024 | January 31, 2029 | CAO, QI | reporter.nih.gov |
| Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer Aggressiveness | NIH | National Cancer Institute | 2022 to 2025 | $1,323,242 | June 17, 2022 | May 31, 2027 | POLLACK, ALAN | reporter.nih.gov |
| Cell Survival Advantage in Cadmium Induced Carcinogenesis | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,322,105 | July 15, 2021 | April 30, 2026 | DAMODARAN, CHENDIL | reporter.nih.gov |
| Molecular origins and evolution to treatment resistance in genitourinary cancers | NIH | National Cancer Institute | 2022 to 2025 | $1,321,652 | August 1, 2022 | July 31, 2027 | PARK, JIHYE | reporter.nih.gov |
| Further assessment of durability of a gene editing therapy for Duchenne muscular dystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,321,604 | August 1, 2019 | April 30, 2027 | YOUNG, COURTNEY S | reporter.nih.gov |
| Small Molecule ERG Inhibitors for Prostate Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,317,983 | July 1, 2024 | June 30, 2029 | BUSHWELLER, JOHN HACKETT | reporter.nih.gov |
| The role of the AR interactome in SBMA | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,317,299 | May 15, 2018 | April 30, 2028 | MERRY, DIANE E | reporter.nih.gov |
| Development of Protein Degraders Targeting EZH2 Non-enzymatic Functions in Prostate Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,306,861 | September 1, 2024 | August 31, 2029 | YU, JINDAN | reporter.nih.gov |
| The Collaborative Care PrTNER (Prevention, Treatment, Navigation, Engagement, Resource) Project | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,305,781 | September 15, 2023 | June 30, 2029 | SANDERS, RENATA ARRINGTON | reporter.nih.gov |
| The role of focal adhesion kinase in therapy resistant prostate tumors | NIH | National Cancer Institute | 2023 to 2025 | $1,304,790 | July 7, 2023 | May 31, 2028 | HUANG, JIAOTI | reporter.nih.gov |
| Mechanisms of androgen-dependent Wolffian duct differentiation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,301,736 | June 1, 2023 | March 31, 2028 | ZHAO, FEI | reporter.nih.gov |
| Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma | NIH | National Cancer Institute | 2023 to 2025 | $1,301,277 | January 1, 2023 | December 31, 2027 | TURNER, DAVID PAUL | reporter.nih.gov |
| SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) | NIH | National Cancer Institute | 2024 to 2025 | $1,300,486 | January 12, 2024 | December 31, 2028 | GARCIA, JOSE M. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Family Health International | Durham, NC | 1 | $213.6 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 13 | $104.5 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 11 | $94 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 35 | $63.2 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 22 | $60.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 25 | $50 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 16 | $42.6 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 11 | $41.9 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 9 | $35.7 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 24 | $35.1 million | 0 | $0 |
| University of Washington | Seattle, WA | 19 | $31 million | 0 | $0 |
| Emory University | Atlanta, GA | 23 | $29.6 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 17 | $28.4 million | 0 | $0 |
| Stanford University | Stanford, CA | 15 | $27.6 million | 0 | $0 |
| Duke University | Durham, NC | 21 | $27.4 million | 0 | $0 |
| Washington University | Saint Louis, MO | 14 | $27.4 million | 0 | $0 |
| The Emmes Company, LLC | Rockville, MD | 1 | $25.3 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 9 | $22.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 11 | $21.1 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 10 | $20.6 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 12 | $20.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 12 | $19.7 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 12 | $19.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 15 | $19.4 million | 0 | $0 |
| University of California at Davis | Davis, CA | 14 | $18.6 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 12 | $18 million | 0 | $0 |
| Yale University | New Haven, CT | 16 | $17.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 11 | $17.1 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 9 | $17 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 10 | $16.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 8 | $15.9 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 14 | $15.3 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 8 | $14.6 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 10 | $14.3 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 8 | $13.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 9 | $13.6 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 7 | $13.1 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 9 | $12.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 10 | $12.6 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 10 | $12.3 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 3 | $11.8 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 7 | $11.8 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 9 | $11.8 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 7 | $11.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 10 | $11.5 million | 0 | $0 |
| University of Chicago | Chicago, IL | 8 | $11.1 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 10 | $10.2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 9 | $10.2 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 4 | $10.1 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 9 | $10.1 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 9 | $9.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 7 | $8.9 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 3 | $8.6 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 7 | $8.5 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 6 | $8.2 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 6 | $8.2 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 7 | $8 million | 0 | $0 |
| Brown University | Providence, RI | 3 | $8 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 5 | $8 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 5 | $7.7 million | 0 | $0 |
| Florida State University | Tallahassee, FL | 3 | $7.6 million | 0 | $0 |
| Wayne State University | Detroit, MI | 6 | $7.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 4 | $7.3 million | 0 | $0 |
| Washington State University | Pullman, WA | 6 | $7.2 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 6 | $7.1 million | 0 | $0 |
| Cold Spring Harbor Laboratory | Cold Spring Harbor, NY | 3 | $6.8 million | 0 | $0 |
| Aurum Institute NPC | Parktown, Johannesburg | 1 | $6.7 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 4 | $6.6 million | 0 | $0 |
| Center for Innovative Public Health Research | San Clemente, CA | 1 | $6.5 million | 0 | $0 |
| George Washington University | Washington, DC | 3 | $6.4 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 3 | $6.4 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 4 | $6.2 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 5 | $6.2 million | 0 | $0 |
| H. Lee Moffitt Cancer CTR & Res Inst | Tampa, FL | 3 | $5.9 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 4 | $5.9 million | 0 | $0 |
| Graduate School of Public Health and Health Policy | New York, NY | 1 | $5.9 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 6 | $5.7 million | 0 | $0 |
| Florida International University | Miami, FL | 5 | $5.4 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 3 | $5.4 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 3 | $5.4 million | 0 | $0 |
| University of Delaware | Newark, DE | 3 | $5.3 million | 0 | $0 |
| San Diego State University Foundation | San Diego, CA | 4 | $5.3 million | 0 | $0 |
| Seattle Inst for Biomedical/clinical Res | Seattle, WA | 3 | $5.2 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 2 | $5.1 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 3 | $5 million | 0 | $0 |
| Ohio State University | Columbus, OH | 3 | $5 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 3 | $4.9 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 3 | $4.8 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 4 | $4.8 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 3 | $4.7 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 4 | $4.7 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 2 | $4.7 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 3 | $4.6 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 4 | $4.4 million | 0 | $0 |
| Georgetown University | Washington, DC | 3 | $4.4 million | 0 | $0 |
| Whitman-Walker Institute, Inc. | Washington, DC | 1 | $4 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 3 | $4 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 3 | $3.7 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 4 | $3.7 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 3 | $3.7 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 985 | $606,723,760 | 0 | $0 |
| 2024 | 756 | $457,674,035 | 0 | $0 |
| 2023 | 533 | $348,340,890 | 0 | $0 |
| 2022 | 350 | $272,684,332 | 0 | $0 |
| 2021 | 206 | $246,001,608 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.